AIM ImmunoTech CEO to Participate in Virtual Panel: 'New Approaches to COVID-19: Hidden Breakthroughs,' on Thursday, September 10th
OCALA, FL / ACCESSWIRE / September 8, 2020 / AIM ImmunoTech Inc. (NYSE American:AIM), today announced that Thomas K. Equels, CEO of AIM ImmunoTech, will participate in a virtual panel titled, "New Approaches...
ImmunoPrecise to Present at The LD 500 Virtual Investor Conference
VICTORIA, BC / ACCESSWIRE / August 31, 2020 / IMMUNOPRECISE ANTIBODIES LTD. (the "Company" or "IPA") (TSXV:IPA)(OTCQB:IPATF)(FSE:TQB2), a leader in full-service, therapeutic antibody discovery and development,...